Literature DB >> 11053627

Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses.

V Blazevic1, C M Trubey, G M Shearer.   

Abstract

Live influenza viruses, heat-inactivated virus, and a trivalent formalin-inactivated influenza vaccine were analyzed for their in vitro stimulatory properties on immune cells from healthy donors. Lymphocyte proliferation induced by each influenza antigen was comparable. Influenza vaccine stimulated significantly lower production of interferon-gamma (IFN-gamma) compared with live and heat inactivated viruses, whereas both vaccine and heat-inactivated influenza induced lower levels of IFN-alpha compared with live virus. Furthermore, only live virus generated influenza-specific cytotoxic T lymphocyte (CTL) activity. A significant increase in monocyte expression of CD80, CD86, CD40, and human leukocyte antigen-DR (HLA-DR) was also induced by live influenza virus. Our results suggest that immunization with live influenza vaccines might induce immune responses that would not be induced by conventional inactivated vaccines, including CTL generation, antiviral IFN-gamma and IFN-alpha cytokine production, and increased antigen presentation and costimulatory capacity on antigen presenting cells (APC).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053627     DOI: 10.1016/s0198-8859(00)00170-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  Induction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathways.

Authors:  William A Langley; Konrad C Bradley; Zhu-Nan Li; Mary Ellen Smith; Matthias J Schnell; David A Steinhauer
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.

Authors:  Joan E Nichols; Jean A Niles; Elisa H Fleming; Norbert J Roberts
Journal:  Virology       Date:  2019-06-10       Impact factor: 3.616

3.  Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.

Authors:  B Ferko; J Stasakova; S Sereinig; J Romanova; D Katinger; B Niebler; H Katinger; A Egorov
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features.

Authors:  Sherry R Crowe; Joan T Merrill; Evan S Vista; Amy B Dedeke; David M Thompson; Scott Stewart; Joel M Guthridge; Timothy B Niewold; Beverly S Franek; Gillian M Air; Linda F Thompson; Judith A James
Journal:  Arthritis Rheum       Date:  2011-08

5.  Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.

Authors:  Sang-Moo Kang; Lizheng Guo; Qizhi Yao; Ioanna Skountzou; Richard W Compans
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.

Authors:  Toshihiro Sawai; Yasushi Itoh; Hiroichi Ozaki; Norikazu Isoda; Kiyoko Okamoto; Yoshitaka Kashima; Yoshihiro Kawaoka; Yoshihiro Takeuchi; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Immunology       Date:  2008-01-16       Impact factor: 7.397

7.  Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

Authors:  Bruce D Forrest; Michael W Pride; Andrew J Dunning; Maria Rosario Z Capeding; Tawee Chotpitayasunondh; John S Tam; Ruth Rappaport; John H Eldridge; William C Gruber
Journal:  Clin Vaccine Immunol       Date:  2008-04-30

8.  Intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza.

Authors:  Junwei Li; Diana Diaz-Arévalo; Yanping Chen; Mingtao Zeng
Journal:  Front Immunol       Date:  2015-04-21       Impact factor: 7.561

9.  Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.

Authors:  Claudia Spies; Alawi Luetz; Gunnar Lachmann; Markus Renius; Clarissa von Haefen; Klaus-Dieter Wernecke; Marcus Bahra; Alexander Schiemann; Marco Paupers; Christian Meisel
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

Review 10.  Host responses from innate to adaptive immunity after vaccination: molecular and cellular events.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  Mol Cells       Date:  2009-02-05       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.